It was learned from the Anhui Provincial Bureau of Science and Technology that the program provides that qualified SMEs can pledge their own patent rights to a guarantee agency, and the guarantee agency provides guarantees to lenders to obtain a certain amount of loans from lenders. Repay loan principal and interest on schedule, thereby alleviating the financing difficulties of SMEs of science and technology, and supporting the development of small and medium-sized high-tech enterprises with independent intellectual property rights.
In order to encourage the guarantee agencies to actively carry out patent pledge loan guarantee activities, the plan stipulates that the guarantee agency can apply to the Hefei Science and Technology Bureau for the payment of the risk compensation after it has first paid for the guarantee debts. After the review meets the conditions for redeeming the risk compensation, The Municipal Bureau of Finance will, within one month, guarantee the guarantee agency to compensate 50% of the risk compensation of the secured debt and allocate it to the guarantee agency in one full amount. At the same time, a one-time award of 1% of the loan amount secured by the guarantee agency’s patent-pledged loan was granted.
In addition, in order to enable more technology-based SMEs to enjoy this preferential policy, Hefei City also appropriately relaxed the loan threshold. The legal person registered in Hefei City complies with the Provisional Regulations on SME Standards. The research and development expenses of the company accounted for more than 4% of the company’s sales revenue in the previous year. The profits in the past two years can maintain stable growth or the company’s With an annual sales income of over 5 million yuan and a profit and tax rate of over 30%, the company has sustainable technological innovation activities such as original innovation, integrated innovation, introduction, digestion, absorption and re-innovation, and it has departments or agencies specialized in research and development that can apply.
The fluorine-containing pharmaceutical reagents developed and produced by ZSEM have obvious advantages in improving the selectivity, efficacy, and physical and chemical properties of candidate drugs.
At present, the important pharmaceutical preparations produced and sold include perfluorotripropylamine CAS#: 338-83-0, perfluorooctyl bromide CAS#: 423-55-2, perfluorohexadecane CAS#: 355-49- 7. Sodium trifluoromethanesulfinate CAS#2926-30-9, Perfluorooctane CAS: 307-34-6, Perfluorotributylamine CAS#: 311-89-7, etc.
Fluorinated Medical Reagents,Perfluorooctyl Bromide Chemical Water Agent,Perfluorooctyl Bromide Perfluorocarbon,Perfluorodecalin Cosmetic Materials
Shandong Zhongshan Photoelectric Materials Co., Ltd , https://www.zshcchem.com